Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Invested Capital: 2018-2025

Historic Return on Invested Capital for Corcept Therapeutics (CORT) over the last 6 years, with Mar 2025 value amounting to 0.16%.

  • Corcept Therapeutics' Return on Invested Capital fell 3.00% to 0.16% in Q1 2025 from the same period last year, while for Mar 2025 it was 0.16%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of 0.20% for FY2024, which is 2.00% up from last year.
  • Per Corcept Therapeutics' latest filing, its Return on Invested Capital stood at 0.16% for Q1 2025, which was down 11.83% from 0.18% recorded in Q4 2024.
  • Corcept Therapeutics' 5-year Return on Invested Capital high stood at 0.28% for Q1 2022, and its period low was 0.16% during Q1 2025.
  • For the 3-year period, Corcept Therapeutics' Return on Invested Capital averaged around 0.18%, with its median value being 0.18% (2024).
  • Per our database at Business Quant, Corcept Therapeutics' Return on Invested Capital grew by 10bps in 2022 and then dropped by 11bps in 2023.
  • Corcept Therapeutics' Return on Invested Capital (Quarterly) stood at 0.24% in 2021, then decreased by 4bps to 0.20% in 2022, then dropped by 1bps to 0.19% in 2023, then fell by 1bps to 0.18% in 2024, then decreased by 3bps to 0.16% in 2025.
  • Its Return on Invested Capital stands at 0.16% for Q1 2025, versus 0.18% for Q4 2024 and 0.20% for Q3 2024.